Dapagliflozin Patient Satisfaction Survey

Clinical trial NCT02805283 · COMPLETED

Trial details

NCT number: NCT02805283
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2016-06-22
Primary completion: 2018-10-29
Enrollment: 653

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.